The global market for Radiopharmaceutical Solutions was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Radiopharmaceutical Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceutical Solutions.

The Radiopharmaceutical Solutions market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radiopharmaceutical Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Radiopharmaceutical Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Radiopharmaceutical Solutions Market Report

Report Metric	Details
Report Name	Radiopharmaceutical Solutions Market
CAGR	5%
Segment by Type	Oral Tracking Vein Tracking
Segment by Application	Hospitals Health Systems Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	IBA, GE Healthcare, Actinium Pharmaceuticals, Alseres Pharmaceuticals, Cardinal Health, Jubilant Pharma, Central Research Laboratories, Cyclomedica, Bracco, Eckert & Ziegler Radiopharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radiopharmaceutical Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Radiopharmaceutical Solutions Market report?

Ans: The main players in the Radiopharmaceutical Solutions Market are IBA, GE Healthcare, Actinium Pharmaceuticals, Alseres Pharmaceuticals, Cardinal Health, Jubilant Pharma, Central Research Laboratories, Cyclomedica, Bracco, Eckert & Ziegler Radiopharma

What are the Application segmentation covered in the Radiopharmaceutical Solutions Market report?

Ans: The Applications covered in the Radiopharmaceutical Solutions Market report are Hospitals, Health Systems, Others

What are the Type segmentation covered in the Radiopharmaceutical Solutions Market report?

Ans: The Types covered in the Radiopharmaceutical Solutions Market report are Oral Tracking, Vein Tracking

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Radiopharmaceutical Solutions Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Oral Tracking

1.2.3 Vein Tracking

1.3 Market by Application

1.3.1 Global Radiopharmaceutical Solutions Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Health Systems

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Radiopharmaceutical Solutions Market Perspective (2020-2031)

2.2 Global Radiopharmaceutical Solutions Growth Trends by Region

2.2.1 Global Radiopharmaceutical Solutions Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Radiopharmaceutical Solutions Historic Market Size by Region (2020-2025)

2.2.3 Radiopharmaceutical Solutions Forecasted Market Size by Region (2026-2031)

2.3 Radiopharmaceutical Solutions Market Dynamics

2.3.1 Radiopharmaceutical Solutions Industry Trends

2.3.2 Radiopharmaceutical Solutions Market Drivers

2.3.3 Radiopharmaceutical Solutions Market Challenges

2.3.4 Radiopharmaceutical Solutions Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Radiopharmaceutical Solutions Players by Revenue

3.1.1 Global Top Radiopharmaceutical Solutions Players by Revenue (2020-2025)

3.1.2 Global Radiopharmaceutical Solutions Revenue Market Share by Players (2020-2025)

3.2 Global Radiopharmaceutical Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Radiopharmaceutical Solutions Revenue

3.4 Global Radiopharmaceutical Solutions Market Concentration Ratio

3.4.1 Global Radiopharmaceutical Solutions Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Radiopharmaceutical Solutions Revenue in 2024

3.5 Global Key Players of Radiopharmaceutical Solutions Head office and Area Served

3.6 Global Key Players of Radiopharmaceutical Solutions, Product and Application

3.7 Global Key Players of Radiopharmaceutical Solutions, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Radiopharmaceutical Solutions Breakdown Data by Type

4.1 Global Radiopharmaceutical Solutions Historic Market Size by Type (2020-2025)

4.2 Global Radiopharmaceutical Solutions Forecasted Market Size by Type (2026-2031)

5 Radiopharmaceutical Solutions Breakdown Data by Application

5.1 Global Radiopharmaceutical Solutions Historic Market Size by Application (2020-2025)

5.2 Global Radiopharmaceutical Solutions Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Radiopharmaceutical Solutions Market Size (2020-2031)

6.2 North America Radiopharmaceutical Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Radiopharmaceutical Solutions Market Size by Country (2020-2025)

6.4 North America Radiopharmaceutical Solutions Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Radiopharmaceutical Solutions Market Size (2020-2031)

7.2 Europe Radiopharmaceutical Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Radiopharmaceutical Solutions Market Size by Country (2020-2025)

7.4 Europe Radiopharmaceutical Solutions Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Radiopharmaceutical Solutions Market Size (2020-2031)

8.2 Asia-Pacific Radiopharmaceutical Solutions Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Radiopharmaceutical Solutions Market Size by Region (2020-2025)

8.4 Asia-Pacific Radiopharmaceutical Solutions Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Radiopharmaceutical Solutions Market Size (2020-2031)

9.2 Latin America Radiopharmaceutical Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Radiopharmaceutical Solutions Market Size by Country (2020-2025)

9.4 Latin America Radiopharmaceutical Solutions Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Radiopharmaceutical Solutions Market Size (2020-2031)

10.2 Middle East & Africa Radiopharmaceutical Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Radiopharmaceutical Solutions Market Size by Country (2020-2025)

10.4 Middle East & Africa Radiopharmaceutical Solutions Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 IBA

11.1.1 IBA Company Details

11.1.2 IBA Business Overview

11.1.3 IBA Radiopharmaceutical Solutions Introduction

11.1.4 IBA Revenue in Radiopharmaceutical Solutions Business (2020-2025)

11.1.5 IBA Recent Development

11.2 GE Healthcare

11.2.1 GE Healthcare Company Details

11.2.2 GE Healthcare Business Overview

11.2.3 GE Healthcare Radiopharmaceutical Solutions Introduction

11.2.4 GE Healthcare Revenue in Radiopharmaceutical Solutions Business (2020-2025)

11.2.5 GE Healthcare Recent Development

11.3 Actinium Pharmaceuticals

11.3.1 Actinium Pharmaceuticals Company Details

11.3.2 Actinium Pharmaceuticals Business Overview

11.3.3 Actinium Pharmaceuticals Radiopharmaceutical Solutions Introduction

11.3.4 Actinium Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2020-2025)

11.3.5 Actinium Pharmaceuticals Recent Development

11.4 Alseres Pharmaceuticals

11.4.1 Alseres Pharmaceuticals Company Details

11.4.2 Alseres Pharmaceuticals Business Overview

11.4.3 Alseres Pharmaceuticals Radiopharmaceutical Solutions Introduction

11.4.4 Alseres Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2020-2025)

11.4.5 Alseres Pharmaceuticals Recent Development

11.5 Cardinal Health

11.5.1 Cardinal Health Company Details

11.5.2 Cardinal Health Business Overview

11.5.3 Cardinal Health Radiopharmaceutical Solutions Introduction

11.5.4 Cardinal Health Revenue in Radiopharmaceutical Solutions Business (2020-2025)

11.5.5 Cardinal Health Recent Development

11.6 Jubilant Pharma

11.6.1 Jubilant Pharma Company Details

11.6.2 Jubilant Pharma Business Overview

11.6.3 Jubilant Pharma Radiopharmaceutical Solutions Introduction

11.6.4 Jubilant Pharma Revenue in Radiopharmaceutical Solutions Business (2020-2025)

11.6.5 Jubilant Pharma Recent Development

11.7 Central Research Laboratories

11.7.1 Central Research Laboratories Company Details

11.7.2 Central Research Laboratories Business Overview

11.7.3 Central Research Laboratories Radiopharmaceutical Solutions Introduction

11.7.4 Central Research Laboratories Revenue in Radiopharmaceutical Solutions Business (2020-2025)

11.7.5 Central Research Laboratories Recent Development

11.8 Cyclomedica

11.8.1 Cyclomedica Company Details

11.8.2 Cyclomedica Business Overview

11.8.3 Cyclomedica Radiopharmaceutical Solutions Introduction

11.8.4 Cyclomedica Revenue in Radiopharmaceutical Solutions Business (2020-2025)

11.8.5 Cyclomedica Recent Development

11.9 Bracco

11.9.1 Bracco Company Details

11.9.2 Bracco Business Overview

11.9.3 Bracco Radiopharmaceutical Solutions Introduction

11.9.4 Bracco Revenue in Radiopharmaceutical Solutions Business (2020-2025)

11.9.5 Bracco Recent Development

11.10 Eckert & Ziegler Radiopharma

11.10.1 Eckert & Ziegler Radiopharma Company Details

11.10.2 Eckert & Ziegler Radiopharma Business Overview

11.10.3 Eckert & Ziegler Radiopharma Radiopharmaceutical Solutions Introduction

11.10.4 Eckert & Ziegler Radiopharma Revenue in Radiopharmaceutical Solutions Business (2020-2025)

11.10.5 Eckert & Ziegler Radiopharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

IBA

GE Healthcare

Actinium Pharmaceuticals

Alseres Pharmaceuticals

Cardinal Health

Jubilant Pharma

Central Research Laboratories

Bracco

Cyclomedica

Eckert & Ziegler Radiopharma

List of Tables

Table 1. Global Radiopharmaceutical Solutions Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Oral Tracking

Table 3. Key Players of Vein Tracking

Table 4. Global Radiopharmaceutical Solutions Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Radiopharmaceutical Solutions Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Radiopharmaceutical Solutions Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Radiopharmaceutical Solutions Market Share by Region (2020-2025)

Table 8. Global Radiopharmaceutical Solutions Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Radiopharmaceutical Solutions Market Share by Region (2026-2031)

Table 10. Radiopharmaceutical Solutions Market Trends

Table 11. Radiopharmaceutical Solutions Market Drivers

Table 12. Radiopharmaceutical Solutions Market Challenges

Table 13. Radiopharmaceutical Solutions Market Restraints

Table 14. Global Radiopharmaceutical Solutions Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Radiopharmaceutical Solutions Market Share by Players (2020-2025)

Table 16. Global Top Radiopharmaceutical Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Solutions as of 2024)

Table 17. Ranking of Global Top Radiopharmaceutical Solutions Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Radiopharmaceutical Solutions Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Radiopharmaceutical Solutions, Headquarters and Area Served

Table 20. Global Key Players of Radiopharmaceutical Solutions, Product and Application

Table 21. Global Key Players of Radiopharmaceutical Solutions, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Radiopharmaceutical Solutions Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Radiopharmaceutical Solutions Revenue Market Share by Type (2020-2025)

Table 25. Global Radiopharmaceutical Solutions Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Radiopharmaceutical Solutions Revenue Market Share by Type (2026-2031)

Table 27. Global Radiopharmaceutical Solutions Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Radiopharmaceutical Solutions Revenue Market Share by Application (2020-2025)

Table 29. Global Radiopharmaceutical Solutions Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Radiopharmaceutical Solutions Revenue Market Share by Application (2026-2031)

Table 31. North America Radiopharmaceutical Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Radiopharmaceutical Solutions Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Radiopharmaceutical Solutions Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Radiopharmaceutical Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Radiopharmaceutical Solutions Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Radiopharmaceutical Solutions Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Radiopharmaceutical Solutions Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Radiopharmaceutical Solutions Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Radiopharmaceutical Solutions Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Radiopharmaceutical Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Radiopharmaceutical Solutions Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Radiopharmaceutical Solutions Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Radiopharmaceutical Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Radiopharmaceutical Solutions Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Radiopharmaceutical Solutions Market Size by Country (2026-2031) & (US$ Million)

Table 46. IBA Company Details

Table 47. IBA Business Overview

Table 48. IBA Radiopharmaceutical Solutions Product

Table 49. IBA Revenue in Radiopharmaceutical Solutions Business (2020-2025) & (US$ Million)

Table 50. IBA Recent Development

Table 51. GE Healthcare Company Details

Table 52. GE Healthcare Business Overview

Table 53. GE Healthcare Radiopharmaceutical Solutions Product

Table 54. GE Healthcare Revenue in Radiopharmaceutical Solutions Business (2020-2025) & (US$ Million)

Table 55. GE Healthcare Recent Development

Table 56. Actinium Pharmaceuticals Company Details

Table 57. Actinium Pharmaceuticals Business Overview

Table 58. Actinium Pharmaceuticals Radiopharmaceutical Solutions Product

Table 59. Actinium Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2020-2025) & (US$ Million)

Table 60. Actinium Pharmaceuticals Recent Development

Table 61. Alseres Pharmaceuticals Company Details

Table 62. Alseres Pharmaceuticals Business Overview

Table 63. Alseres Pharmaceuticals Radiopharmaceutical Solutions Product

Table 64. Alseres Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2020-2025) & (US$ Million)

Table 65. Alseres Pharmaceuticals Recent Development

Table 66. Cardinal Health Company Details

Table 67. Cardinal Health Business Overview

Table 68. Cardinal Health Radiopharmaceutical Solutions Product

Table 69. Cardinal Health Revenue in Radiopharmaceutical Solutions Business (2020-2025) & (US$ Million)

Table 70. Cardinal Health Recent Development

Table 71. Jubilant Pharma Company Details

Table 72. Jubilant Pharma Business Overview

Table 73. Jubilant Pharma Radiopharmaceutical Solutions Product

Table 74. Jubilant Pharma Revenue in Radiopharmaceutical Solutions Business (2020-2025) & (US$ Million)

Table 75. Jubilant Pharma Recent Development

Table 76. Central Research Laboratories Company Details

Table 77. Central Research Laboratories Business Overview

Table 78. Central Research Laboratories Radiopharmaceutical Solutions Product

Table 79. Central Research Laboratories Revenue in Radiopharmaceutical Solutions Business (2020-2025) & (US$ Million)

Table 80. Central Research Laboratories Recent Development

Table 81. Cyclomedica Company Details

Table 82. Cyclomedica Business Overview

Table 83. Cyclomedica Radiopharmaceutical Solutions Product

Table 84. Cyclomedica Revenue in Radiopharmaceutical Solutions Business (2020-2025) & (US$ Million)

Table 85. Cyclomedica Recent Development

Table 86. Bracco Company Details

Table 87. Bracco Business Overview

Table 88. Bracco Radiopharmaceutical Solutions Product

Table 89. Bracco Revenue in Radiopharmaceutical Solutions Business (2020-2025) & (US$ Million)

Table 90. Bracco Recent Development

Table 91. Eckert & Ziegler Radiopharma Company Details

Table 92. Eckert & Ziegler Radiopharma Business Overview

Table 93. Eckert & Ziegler Radiopharma Radiopharmaceutical Solutions Product

Table 94. Eckert & Ziegler Radiopharma Revenue in Radiopharmaceutical Solutions Business (2020-2025) & (US$ Million)

Table 95. Eckert & Ziegler Radiopharma Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Radiopharmaceutical Solutions Picture

Figure 2. Global Radiopharmaceutical Solutions Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Radiopharmaceutical Solutions Market Share by Type: 2024 VS 2031

Figure 4. Oral Tracking Features

Figure 5. Vein Tracking Features

Figure 6. Global Radiopharmaceutical Solutions Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Radiopharmaceutical Solutions Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Health Systems Case Studies

Figure 10. Others Case Studies

Figure 11. Radiopharmaceutical Solutions Report Years Considered

Figure 12. Global Radiopharmaceutical Solutions Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Radiopharmaceutical Solutions Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Radiopharmaceutical Solutions Market Share by Region: 2024 VS 2031

Figure 15. Global Radiopharmaceutical Solutions Market Share by Players in 2024

Figure 16. Global Top Radiopharmaceutical Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Solutions as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Radiopharmaceutical Solutions Revenue in 2024

Figure 18. North America Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Radiopharmaceutical Solutions Market Share by Country (2020-2031)

Figure 20. United States Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Radiopharmaceutical Solutions Market Share by Country (2020-2031)

Figure 24. Germany Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Radiopharmaceutical Solutions Market Share by Region (2020-2031)

Figure 32. China Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Radiopharmaceutical Solutions Market Share by Country (2020-2031)

Figure 40. Mexico Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Radiopharmaceutical Solutions Market Share by Country (2020-2031)

Figure 44. Turkey Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Radiopharmaceutical Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. IBA Revenue Growth Rate in Radiopharmaceutical Solutions Business (2020-2025)

Figure 48. GE Healthcare Revenue Growth Rate in Radiopharmaceutical Solutions Business (2020-2025)

Figure 49. Actinium Pharmaceuticals Revenue Growth Rate in Radiopharmaceutical Solutions Business (2020-2025)

Figure 50. Alseres Pharmaceuticals Revenue Growth Rate in Radiopharmaceutical Solutions Business (2020-2025)

Figure 51. Cardinal Health Revenue Growth Rate in Radiopharmaceutical Solutions Business (2020-2025)

Figure 52. Jubilant Pharma Revenue Growth Rate in Radiopharmaceutical Solutions Business (2020-2025)

Figure 53. Central Research Laboratories Revenue Growth Rate in Radiopharmaceutical Solutions Business (2020-2025)

Figure 54. Cyclomedica Revenue Growth Rate in Radiopharmaceutical Solutions Business (2020-2025)

Figure 55. Bracco Revenue Growth Rate in Radiopharmaceutical Solutions Business (2020-2025)

Figure 56. Eckert & Ziegler Radiopharma Revenue Growth Rate in Radiopharmaceutical Solutions Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Residential & Nursing Care Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30L18812

Tue Mar 11 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Self-Contained Biological Indicators for Steam Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0R19493

Tue Mar 11 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Human Serum Albumin Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13S8713

Mon Mar 10 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Radioimmunotherapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4N14003

Mon Mar 10 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions